clinical trial · NCT07243379
A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia
Changchun GeneScience Pharmaceutical Co., Ltd.·phase4·recruiting·n = 495
Clinical Characteristics and Treatment Outcomes of Malignant Tumor CachexiaMulticenter Observational StudyNanocrystalline Megestrol Acetate
brief summary
This study is a prospective, real-world observational study. The objective is to evaluate the effectiveness and safety of nanocrystalline megestrol acetate in patients with cancer cachexia in real-world settings. Eligible participants were patients diagnosed with cancer cachexia who were scheduled to receive treatment with nanocrystalline megestrol acetate.
started
Sep 25, 2025
primary completion
Dec 31, 2026
completion
Jun 30, 2027
last updated
Nov 21, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol